Literature DB >> 30927944

Radiogenomics of rectal adenocarcinoma in the era of precision medicine: A pilot study of associations between qualitative and quantitative MRI imaging features and genetic mutations.

Natally Horvat1, Harini Veeraraghavan2, Raphael A Pelossof3, Maria Clara Fernandes4, Arshi Arora5, Monika Khan6, Michael Marco3, Chin-Tung Cheng3, Mithat Gonen5, Jennifer S Golia Pernicka6, Marc J Gollub6, Julio Garcia-Aguillar3, Iva Petkovska7.   

Abstract

OBJECTIVE: To investigate associations between genetic mutations and qualitative as well as quantitative features on MRI in rectal adenocarcinoma at primary staging.
METHODS: In this retrospective study, patients with rectal adenocarcinoma, genome sequencing, and pretreatment rectal MRI were included. Statistical analysis was performed to evaluate associations between qualitative features obtained from subjective evaluation of rectal MRI and gene mutations as well as between quantitative textural features and gene mutations. For the qualitative evaluation, Fisher's Exact test was used to analyze categorical associations and Wilcoxon Rank Sum test was used for continuous clinical variables. For the quantitative evaluation, we performed manual segmentation of T2-weighted images for radiomics-based quantitative image analysis. Thirty-four texture features consisting of first order intensity histogram-based features (n = 4), second order Haralick textures (n = 5), and Gabor-edge based Haralick textures were computed at two different orientations. Consensus clustering was performed with 34 computed texture features using the K-means algorithm with Euclidean distance between the texture features. The clusters resulting from the algorithm were then used to enumerate the prevalence of gene mutations in those clusters.
RESULTS: In 65 patients, 45 genes were mutated in more than 3/65 patients (5%) and were included in the statistical analysis. Regarding qualitative imaging features, on univariate analysis, tumor location was significantly associated with APC (p = 0.032) and RASA1 mutation (p = 0.032); CRM status was significantly associated with ATM mutation (p = 0.021); and lymph node metastasis was significantly associated with BRCA2 (p = 0.046) mutation. However, these associations were not significant after adjusting for multiple comparisons. Regarding quantitative imaging features, Cluster C1 had tumors with higher mean Gabor edge intensity compared with cluster C2 (θ = 0°, p = 0.018; θ = 45°, p = 0.047; θ = 90°, p = 0.037; cluster C3 (θ = 0°, p = 0.18; θ = 45°, p = 0.1; θ = 90°, p = 0.052), and cluster C4 (θ = 0°, p = 0.016; θ = 45°, p = 0.033; θ = 90°, p = 0.014) suggesting that the cluster C1 had tumors with more distinct edges or heterogeneous appearance compared with other clusters.
CONCLUSIONS: Although this preliminary study showed promising associations between quantitative features and genetic mutations, it did not show any correlation between qualitative features and genetic mutations. Further studies with larger sample size are warranted to validate our preliminary data.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Genomics; Magnetic resonance imaging; Precision medicine; Rectal neoplasms

Mesh:

Year:  2019        PMID: 30927944      PMCID: PMC6443100          DOI: 10.1016/j.ejrad.2019.02.022

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  27 in total

1.  Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations.

Authors:  Christoph A Karlo; Pier Luigi Di Paolo; Joshua Chaim; A Ari Hakimi; Irina Ostrovnaya; Paul Russo; Hedvig Hricak; Robert Motzer; James J Hsieh; Oguz Akin
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

2.  The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the "DISTANCE"?

Authors:  Stephanie Nougaret; Caroline Reinhold; Hisham W Mikhael; Philippe Rouanet; Frédéric Bibeau; Gina Brown
Journal:  Radiology       Date:  2013-08       Impact factor: 11.105

3.  Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.

Authors:  Donavan T Cheng; Talia N Mitchell; Ahmet Zehir; Ronak H Shah; Ryma Benayed; Aijazuddin Syed; Raghu Chandramohan; Zhen Yu Liu; Helen H Won; Sasinya N Scott; A Rose Brannon; Catherine O'Reilly; Justyna Sadowska; Jacklyn Casanova; Angela Yannes; Jaclyn F Hechtman; Jinjuan Yao; Wei Song; Dara S Ross; Alifya Oultache; Snjezana Dogan; Laetitia Borsu; Meera Hameed; Khedoudja Nafa; Maria E Arcila; Marc Ladanyi; Michael F Berger
Journal:  J Mol Diagn       Date:  2015-03-20       Impact factor: 5.568

Review 4.  TP53 mutation in colorectal cancer.

Authors:  Barry Iacopetta
Journal:  Hum Mutat       Date:  2003-03       Impact factor: 4.878

5.  Genetic variation and alterations of genes involved in NFκB/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer.

Authors:  Jonas Ungerbäck; Dimitri Belenki; Aksa Jawad ul-Hassan; Mats Fredrikson; Karin Fransén; Nils Elander; Deepti Verma; Peter Söderkvist
Journal:  Carcinogenesis       Date:  2012-07-28       Impact factor: 4.944

Review 6.  Breast MRI radiogenomics: Current status and research implications.

Authors:  Lars J Grimm
Journal:  J Magn Reson Imaging       Date:  2015-12-10       Impact factor: 4.813

7.  Genetic alterations in colorectal cancer.

Authors:  Tannaz Armaghany; Jon D Wilson; Quyen Chu; Glenn Mills
Journal:  Gastrointest Cancer Res       Date:  2012-01

8.  Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study.

Authors:  H J Andreyev; A R Norman; D Cunningham; J Oates; B R Dix; B J Iacopetta; J Young; T Walsh; R Ward; N Hawkins; M Beranek; P Jandik; R Benamouzig; E Jullian; P Laurent-Puig; S Olschwang; O Muller; I Hoffmann; H M Rabes; C Zietz; C Troungos; C Valavanis; S T Yuen; J W Ho; C T Croke; D P O'Donoghue; W Giaretti; A Rapallo; A Russo; V Bazan; M Tanaka; K Omura; T Azuma; T Ohkusa; T Fujimori; Y Ono; M Pauly; C Faber; R Glaesener; A F de Goeij; J W Arends; S N Andersen; T Lövig; J Breivik; G Gaudernack; O P Clausen; P D De Angelis; G I Meling; T O Rognum; R Smith; H S Goh; A Font; R Rosell; X F Sun; H Zhang; J Benhattar; L Losi; J Q Lee; S T Wang; P A Clarke; S Bell; P Quirke; V J Bubb; J Piris; N R Cruickshank; D Morton; J C Fox; F Al-Mulla; N Lees; C N Hall; D Snary; K Wilkinson; D Dillon; J Costa; V E Pricolo; S D Finkelstein; J S Thebo; A J Senagore; S A Halter; S Wadler; S Malik; K Krtolica; N Urosevic
Journal:  Br J Cancer       Date:  2001-09-01       Impact factor: 7.640

9.  Correlations of dynamic contrast-enhanced magnetic resonance imaging with morphologic, angiogenic, and molecular prognostic factors in rectal cancer.

Authors:  Hye-Suk Hong; Se Hoon Kim; Hae-Jeong Park; Mi-Suk Park; Ki Whang Kim; Won Ho Kim; Nam Kyu Kim; Jae Mun Lee; Hyeon Je Cho
Journal:  Yonsei Med J       Date:  2013-01-01       Impact factor: 2.759

10.  Radiomics: Images Are More than Pictures, They Are Data.

Authors:  Robert J Gillies; Paul E Kinahan; Hedvig Hricak
Journal:  Radiology       Date:  2015-11-18       Impact factor: 11.105

View more
  13 in total

Review 1.  Radiomics-Guided Precision Medicine Approaches for Colorectal Cancer.

Authors:  Mohammed I Quraishi
Journal:  Front Oncol       Date:  2022-06-09       Impact factor: 5.738

2.  Artificial Intelligence and Precision Medicine: A Perspective.

Authors:  Jacek Lorkowski; Oliwia Kolaszyńska; Mieczysław Pokorski
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Structured Reporting of Rectal Cancer Staging and Restaging: A Consensus Proposal.

Authors:  Vincenza Granata; Damiano Caruso; Roberto Grassi; Salvatore Cappabianca; Alfonso Reginelli; Roberto Rizzati; Gabriele Masselli; Rita Golfieri; Marco Rengo; Daniele Regge; Giuseppe Lo Re; Silvia Pradella; Roberta Fusco; Lorenzo Faggioni; Andrea Laghi; Vittorio Miele; Emanuele Neri; Francesca Coppola
Journal:  Cancers (Basel)       Date:  2021-04-28       Impact factor: 6.639

Review 4.  The application of radiomics in predicting gene mutations in cancer.

Authors:  Yana Qi; Tingting Zhao; Mingyong Han
Journal:  Eur Radiol       Date:  2022-01-20       Impact factor: 5.315

Review 5.  The importance of MRI for rectal cancer evaluation.

Authors:  Maria Clara Fernandes; Marc J Gollub; Gina Brown
Journal:  Surg Oncol       Date:  2022-03-18       Impact factor: 2.388

Review 6.  Biomarkers in Colorectal Cancer: Current Research and Future Prospects.

Authors:  Olorunseun O Ogunwobi; Fahad Mahmood; Akinfemi Akingboye
Journal:  Int J Mol Sci       Date:  2020-07-27       Impact factor: 5.923

Review 7.  Colorectal cancer: Parametric evaluation of morphological, functional and molecular tomographic imaging.

Authors:  Pier Paolo Mainenti; Arnaldo Stanzione; Salvatore Guarino; Valeria Romeo; Lorenzo Ugga; Federica Romano; Giovanni Storto; Simone Maurea; Arturo Brunetti
Journal:  World J Gastroenterol       Date:  2019-09-21       Impact factor: 5.742

8.  Clinical utility of radiomics at baseline rectal MRI to predict complete response of rectal cancer after chemoradiation therapy.

Authors:  Iva Petkovska; Florent Tixier; Eduardo J Ortiz; Jennifer S Golia Pernicka; Viktoriya Paroder; David D Bates; Natally Horvat; James Fuqua; Juliana Schilsky; Marc J Gollub; Julio Garcia-Aguilar; Harini Veeraraghavan
Journal:  Abdom Radiol (NY)       Date:  2020-11

9.  Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma.

Authors:  Harini Veeraraghavan; Herbert Alberto Vargas; Alejandro-Jiménez Sánchez; Maura Micco; Eralda Mema; Yulia Lakhman; Mireia Crispin-Ortuzar; Erich P Huang; Douglas A Levine; Rachel N Grisham; Nadeem Abu-Rustum; Joseph O Deasy; Alexandra Snyder; Martin L Miller; James D Brenton; Evis Sala
Journal:  Cancers (Basel)       Date:  2020-11-17       Impact factor: 6.639

10.  Radiomic analysis of MRI to Predict Sustained Complete Response after Radiofrequency Ablation in Patients with Hepatocellular Carcinoma - A Pilot Study.

Authors:  Natally Horvat; Jose de Arimateia B Araujo-Filho; Antonildes N Assuncao-Jr; Felipe Augusto de M Machado; John A Sims; Camila Carlos Tavares Rocha; Brunna Clemente Oliveira; Joao Vicente Horvat; Claudia Maccali; Anna Luísa Boschiroli Lamanna Puga; Aline Lopes Chagas; Marcos Roberto Menezes; Giovanni Guido Cerri
Journal:  Clinics (Sao Paulo)       Date:  2021-07-16       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.